Lloyd Price

APRIL 27, 2024

It can be used to create new drugs, develop personalized treatment plans, and even generate synthetic medical data. But how can healthcare organisations best leverage this technology? A framework called the "Taker-Shaper-Maker" model can be used to describe how organisations can adopt generative AI.

healthcare technology 68

healthcare technology Leadership Drug Development Digital Health 68

Digital Health Global

MARCH 16, 2023

We are excited to support Seamless Therapeutics in its pursuit of taking a leadership position in the rapidly evolving gene editing arena,” added Karl Nägler, PhD, Managing Partner at Wellington Partners. “At billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

JANUARY 23, 2024

It can test thousands of protocol variations and discover the optimal trial design for success, helping research and development (R&D) teams more accurately and rapidly predict clinical trial results and decide whether a trial should proceed, how to optimize cohorts, whether drugs can be repurposed, and other crucial factors.

Drug Development 110

Drug Development Pharmaceuticals Life Science BioTech 110

Healthcare IT Today

JANUARY 17, 2024

The coming year will see exploration of how to apply the technology, but we will not yet see a full integration of generative AI within labeling. Automation in the form of generative artificial intelligence within labeling is highly anticipated, but it will take time to build confidence in the technology.

Health IT 127

Health IT Mental health Interoperability Patient Experience 127